As Part of Cost-Cutting Plan, Teva Will Shut Down Twenty or More Manufacturing Sites | Ctech
A Look At Teva's Paragard IUD Asset Sale To Cooper Companies, From Both Sides
Teva: 35% of senior management are women - Globes
Teva Pharmaceutical Industries Stock Jumps on a Rare Bullish View | Barron's
Most Active Foreign Bonds 21.05.2021 – Teva Pharma, Gazprom, New York Life, Deutsche Bahn, Russian Railways, UBS London Branch – Financial Markets Blog
Generic Drug Lawsuit Could Mean Big Fines for Teva, Mylan: UBS
Rhode Island takes Teva to trial in multibillion-dollar opioid case | Nasdaq
UBS Sees China Private Banking Revenue Pool Hitting $163 Billion - BNN Bloomberg
UBS — EMMA KOLB
Watch What You Need to Know: China, UBS, TEVA - Bloomberg
Teva's Legal Overhang Triggers UBS Downgrade, Near-Halving Of Price Target
Most Active Foreign Bonds 21.05.2021 – Teva Pharma, Gazprom, New York Life, Deutsche Bahn, Russian Railways, UBS London Branch – Financial Markets Blog
UBS raises Teva price target - Globes
Brussels' Teva probe reveals dark side of patent protections | Financial Times
Miles O'Meara - New York City Metropolitan Area | Professional Profile | LinkedIn
Opioid Epidemic Settlement? What Purdue's Rumored Deal Means For Teva, Allergan | Investor's Business Daily
Teva's collapse – Israel's biotech recovery - The Jerusalem Post
Storbank blåstempler Kåre Schultz' plan for Teva: Aktien er »for billig til at ignorere«
Teva Plummets on Downgrade Following $85M Opioid Settlement - TheStreet
Suffering from missteps, drugmaker Teva struggles to heal own ills | The Times of Israel
Exclusive: UBS in talks with China Life for China asset management JV - sources - Headquarters Finance
